<DOC>
	<DOCNO>NCT01901679</DOCNO>
	<brief_summary>The study plan find whether Celebrex may potentially useful decrease inflammation fat tissue thereby low production substance estrogens may increase risk develop breast cancer lead poor outcome disease .</brief_summary>
	<brief_title>Celecoxib Inhibition Aromatase Expression Inflammation Adipose Tissue Obese Postmenopausal Women</brief_title>
	<detailed_description>This study seek examine effective celebrex may reduce inflammation , crown-like structure fat tissue , enzyme aromatase , PGE-M urine estrogen blood urine . Volunteer subject expect stay hospital 2 week take Celebrex approximately 10 day eat diet similar consume coming hospital study .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>Postmenopausal woman define : 24 consecutive month without menstrual period currently take medication know induce amenorrhea . Serum estradiol &lt; 20 pg/mL Body Mass Index 3550 Stable weight define ( +/ 5 % ) body weight least three month 4070 year age Fluent English Known hypersensitivity celecoxib sulfonamide Known peptic ulcer disease Hypertension BP &gt; 150/90 ( 2 occasion rest ) Fasting blood glucose &gt; 165 mg/dL HIV positive Screening creatinine &gt; 2X upper limit normal Screening LFT result &gt; 2x upper limit normal Smokers ( stop &lt; 3 month ago ) Framingham risk score &gt; 15 Evidence active coronary disease history and/or EKG Subjects consume 25 gram soy protein/day 45 mg isoflavones/day , subject consume amount soy , may stop 14 day prior admission Currently take NSAIDS , aspirin , ( &gt; week , stop &lt; 30 day ago ) . Consuming &gt; 3 serving fish seafood/week Currently take fish oil , omega3 supplement herbal supplement exceed GRAS ( Generally Recognized Safe ) level , ( currently take fish oil/omega3 supplement , must 30 day washout period ) Current use anticoagulant Currently take weight control medication Currently take thioridazine Currently take lithium Currently take estrogen/progesterone hormone include vaginal cream , estring , vaginal tablet Currently take medication alter fat store determine principal investigator History Inflammatory Bowel Disease chronic inflammatory disorder History malignancy nonmelanoma skin cancer past 5 year History bleed disorder History cardiovascular disease Diagnosis asthma Any medical , psychological social condition , opinion Investigator , would jeopardize health wellbeing participant study procedure integrity data .</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Obesity</keyword>
	<keyword>Post-menopausal</keyword>
</DOC>